Skip to main content

Table 1 The characteristics of eight CRC patients in our study

From: Multi-omics analyses of human colorectal cancer revealed three mitochondrial genes potentially associated with poor outcomes of patients

  I–II III–IV
Age
 ≤ 65 0 (0.0%) 1 (12.5%)
 > 65 4 (50.0%) 3 (37.5%)
Type
 Adenocarcinoma 4 (50.0%) 4 (50.0%)
Sex
 Male 1 (12.5%) 3 (37.5%)
 Female 3 (37.5%) 1 (12.5%)
T-stage
 T1 1 (12.5%) 0 (0.0%)
 T2 0 (0.0%) 0 (0.0%)
 T3 2 (25.0%) 1 (12.5%)
 T4 1 (12.5%) 3 (37.5%)
N-stage
 N0 4 (50.0%) 0 (0.0%)
 N1 0 (0.0%) 4 (50.0%)
 N2 0 (0.0%) 0 (0.0%)
M-stage
 M0 4 (50.0%) 1 (12.5%)
 M1 0 (0.0%) 3 (37.5%)
Location
 Ascending colon 2 (25.0%) 1 (12.5%)
 Sigmoid colon 1 (12.5%) 3 (37.5%)
 Appendix colon 1 (12.5%) 0 (0.0%)
Chemotherapy
 Yes 0 (0.0%) 0 (0.0%)
 No 4 (50.0%) 4 (50.0%)